The human leucocyte antigen (HLA) region has a major influence on susceptibility to Type I diabetes [1] and is possibly implicated in susceptibility to diabetic complications. Human leucocyte antigen-identical, non-diabetic siblings of diabetic probands have glomerular basement membrane expansion, which is not observed in HLA-non-identical siblings [2] . This is also observed in DR4 positive parents of diabetic patients, suggesting that even in the absence of diabetes, microangiopathy may occur due to HLA-related factors [2] . Previous examination of HLA in nephropathy has shown positive and negative associations with A2, B8, B15, DR4 and DR3/4 [3]. The insulin gene (INS) is also associated with Type I diabetes, and has been implicated in the onset of vascular disease [4] . As macrovascular disease is common in nephropathy, INS is a suitable candidate gene for susceptibility to nephropathy. Previous studies suggest an excess of class I allele homozygotes in patients with nephropathy [4] .
Subjects and methods
Subjects. The patients in this study have been previously described [5] . Three white Caucasian Type I diabetic cohorts were typed. The nephropathy cohort (n = 258) had persistent ªAlbustixº positive proteinuria in the absence of other causes, retinopathy and hypertension. Recently diagnosed Type I diabetic patients were typed (sporadic diabetic group n = 264), as were patients with Type I diabetes longer than 20 years without proteinuria [long duration non-nephropathy (LDNN) group n = 153].
±23Hph1 INS typing. The ±23Hph1 polymorphism of INS has an A/T transversion at position 23, giving rise to a variable restriction site used to visualise class I and class III alleles. Genotyping was done using the Taqman LS-50B Detection System (PE, Applied Biosystems, Norwalk, Conn., USA), using fluorogenic probes INS-AT1 (5 ¢-FAM-CCTGCCTGTCTCCCA-GATCACT-TAMRA-3 ¢) and INS-AT2 (5 ¢-TET-CCTGCTG TCACCCAGATCACT-TAMRA-3 ¢) and the primers INS-T1 (5 ¢-CAAGCAG GTCTGTTCCAAGG-3 ¢) and INS-T2 (5 ¢-GGTCTTGGGTGTGTAGAA GAAGC-3 ¢). This method obviates the need to do post PCR processing. 67 % of INS types obtained in this way were confirmed using conventional restriction fragment length polymorphism (RFLP) analysis. The reaction volume of 50 ml contained 2 ml of each probe (2 pmol.ml ±1 ), 5 ml of 10´buffer (Perkin Elmer, Beaconsfield, UK), 15 mmol/l magnesium chloride (Bioline, London, UK), 10 ml of 50 % glycerol, 4 nmol/l of each dNTP (Pharmacia, Biotech, Uppsala, UK), 1 unit of Taq polymerase (Perkin Elmer), 2 pmoles of each primer and 100 ng of genomic DNA. Two stage PCR conditions were 94°C for 1 min and 63°C for 15 s for 40 cycles. Following PCR, the products were transferred to a viewing plate and fluorescence was read by the Taqman LS-50B luminescence spectrophotometer (PE Applied Biosystems). Genotypes were reported in comparison to samples with known genotypes homozygous for the + allele and ± allele.
HLA typing. Not all samples could be HLA typed due to a large number of assay failures secondary to heparinisation, which can inhibit HLA typing [6] . We typed 200 sporadic, 126 LDNN and 182 nephropathy patients, using the phototyping method [7] which involves typing for HLA-A, B, C, DR, DQA1 and DQB1 using a mix of 144 sequence specific primers. The reaction volume of 13 ml contained 67 mmol/l Tris base pH 8. Statistical analysis. Statistical analysis of INS and HLA genotypes was done using c 2 analysis with Bonferoni correction for the number of tests done.
Results
No significant difference was seen between the LDNN and nephropathy groups in HbA 1 c , age, duration of diabetes, serum cholesterol and age at diagnosis (Table 1 ). Significant higher serum creatinine, systolic blood pressure, diastolic blood pressure, and proportion of males were seen in the nephropathy group (p < 0.01).
For the sake of brevity, results of HLA-A, B and C typing in the three diabetic cohorts are not shown. No significant heterogeneity between the three cohorts in allele distribution was seen in any of the HLA-A, B and C alleles, including the alleles A2, B8 and B15 which had previously shown association.
No heterogeneity between the three cohorts in DR genotype was seen ( Table 2 ). The DR3/4 genotype was not over-represented in the nephropathy group compared with the sporadic (c 2 = 0.549, 1 df, p = 0.459), nor the LDNN (c 2 = 1.160, 1 df, p = 0.282) groups. The DR4 allele was not over-represented in the nephropathy cohort compared with the sporadic (c 2 = 0.003, 1 df, p = 0.954) or LDNN (c 2 = 0.103, 1 df, p = 0.749) groups. No over-representation of DQB1 or DQA1 alleles in the nephropathy group was seen compared with the sporadic or LDNN groups (Table 2) , although the DQB1*0602 allele was slightly more prevalent in the nephropathy cohort, but the numbers were small and not statistically significant. The HLA haplotype distribution (DR-DQA1-DQB1) was compared between the three groups (Table 2) . No significant heterogeneity between the three groups was seen. As our assay was unable to distinguish between DRB1*0401±22 alleles, we were unable to analyse DR4 subtypes according to DQA1/DQB1 haplotypes. The ±23Hph`+ ' allele is equivalent to the class I allele and the`-`allele is equivalent to the class III allele in Caucasian populations. There was no overall heterogeneity between the groups in INS genotypes (c 2 = 2.847, 4 df, p = 0.584). Genotype frequencies did neither differ between the sporadic diabetic group and the nephropathy group (c 2 = 1.203, 2 df, p = 0.548), nor the LDNN group (c 2 = 2.3051, 2 df, p = 0.316). No excess in either the`+ ' or`-' allele was seen in the nephropathy group compared with the sporadic group (c 2 = 1.336, 1 df, p = 0.248), nor the LDNN group (c 2 = 1.543, 1 df, p = 0.215). Consistent with this, no overall heterogeneity in allele frequency was seen between the three groups (c 2 = 2.061, 2 df, p = 0.357). The distribution of INS class I and II alleles according to HLA haplotype was analysed, and again no significant heterogeneity was noted (data not shown).
Discussion
This study is the largest examining HLA and INS genes in nephropathy in Type I diabetes. The results are consistent with previously observed data of the prevalence of diabetes susceptibility and protective alleles in Type I diabetic groups. The DQB1*0302 Data are n (%) or proportion X = non 3 or 4 allele Only haplotypes with more than two subjects shown and *0201 alleles were highly prevalent in all three diabetic groups, whereas the DQB1*0602 and *0603 alleles were uncommon. Furthermore, over 95 % of patients in the diabetic groups had high risk HLA-DR3 or 4 alleles. Similarly, on examination of the INS region, overall 77.4 % of the diabetic cohort had homozygosity for class I alleles which is similar to that seen in previously reported Caucasian populations with Type I diabetes. Several small studies have examined HLA and INS in diabetic complications. These have been reviewed and have shortcomings of small numbers and poor patient characterisation [3] . Unsurprisingly, a number of contradictory results have been reported. Recently, higher prevalence of HLA-DQB1*0201/ 0302 genotype has been suggested in patients with severe retinopathy compared with those free of retinopathy [8] , and the presence of HLA-A24 has also been suggested to be a risk factor for early onset retinopathy, possibly due to more rapid loss of beta-cell function associated with this allele. Whilst hyperglycaemia is important in the pathogenesis of nephropathy, early beta-cell failure is probably not a major influence on the development of nephropathy as patients with nephropathy appear to be more insulin resistant than their non-nephropathic counterparts.
Larger studies of HLA in nephropathy have been reported recently. A study examined 24 patients with diabetic nephropathy and 51 patients with long duration of diabetes and no nephropathy and showed a significant protective effect of the DR4 allele (p = 0.02) [9] . In a similar study, INS and HLA regions were examined in 26 patients with Type I diabetes and microalbuminuria and 30 subjects matched for age, sex and HbA 1 c who were normoalbuminuric [10] . No significant difference in INS genotypes and alleles was noted, and there was no association with HLA. The cohort studied in the Wisconsin Epidemiologic Study of Diabetic Retinopathy has also been examined for genetic factors involved in diabetic nephropathy [4] . The study assessed 324 of the original cohort of 996 for nephropathy status. It was noted at initial examination that subjects with proteinuria were more likely to be class I homozygotes (I/I ± 19 % vs I/III or III/III ± 10 %, p < 0.05), although the nephropathy cohort was small (n = 50).
In this study no association between INS, HLA-A, B, C, DR, DQA1 and DQB1 alleles and nephropathy was seen on examination of large, well characterised cohorts of patients with Type I diabetes with and without nephropathy. In particular, the previously reported positive and negative associations with HLA A2, B8, B15, DR3/4, DR4 and INS class I alleles could not be confirmed. No association with HLA haplotypes was noted. It is unlikely, therefore, that HLA and INS modulate the genetic influence in diabetic nephropathy in Caucasian subjects with Type I diabetes in the United Kingdom.
